EI7

4,5,6,7-tetrahydro-[1,2]oxazolo[5,4-c]pyridin-3-one


Toggle HydrogenToggle Labels

Chemical Component Summary

Name4,5,6,7-tetrahydro-[1,2]oxazolo[5,4-c]pyridin-3-one
Synonymsgaboxadol
Identifiers4,5,6,7-tetrahydro-[1,2]oxazolo[5,4-c]pyridin-3-one
FormulaC6 H8 N2 O2
Molecular Weight140.14
TypeNON-POLYMER
Isomeric SMILESC1CNCC2=C1C(=O)NO2
InChIInChI=1S/C6H8N2O2/c9-6-4-1-2-7-3-5(4)10-8-6/h7H,1-3H2,(H,8,9)
InChIKeyZXRVKCBLGJOCEE-UHFFFAOYSA-N

Chemical Details

Formal Charge0
Atom Count18
Chiral Atom Count0
Bond Count19
Aromatic Bond Count0

Drug Info: DrugBank

DrugBank IDDB06554 
NameGaboxadol
Groups investigational
DescriptionGaboxadol also known as 4,5,6,7-tetrahydroisoxazolo(5,4-c)pyridin-3-ol (THIP) is an experimental sleep aid drug developed by Lundbeck and Merck, who reported increased deep sleep without the reinforcing effects of benzodiazepines. Development of Gaboxadol was stopped in March 2007 after concerns regarding safety and efficacy. It acts on the GABA system, but in a seemingly different way from benzodiazepines and other sedatives.
Synonyms
  • 4,5,6,7-tetrahydroisoxazolo(5,4-c)pyridin-3-ol
  • THIP
  • Gaboxadol
IndicationInvestigated for use/treatment in sleep disorders and insomnia.
Categories
  • Analgesics
  • Anesthetics
  • Anticonvulsants
  • Appetite Depressants
  • Central Nervous System Agents
CAS number64603-91-4

Drug Targets

NameTarget SequencePharmacological ActionActions
Proton-coupled amino acid transporter 1MSTQRLRNEDYHDYSSTDVSPEESPSEGLNNLSSPGSYQRFGQSNSTTWF...unknownsubstrate
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource NameReference
PubChem 28360827, 3448
ChEMBL CHEMBL312443
ChEBI CHEBI:34373